Biotech News

Bristol Myers Squibb Announces Dividend

BMYBristol-Myers Squibb Company (BMY)BMYBristol-Myers Squibb CompanyCompany update

Bristol Myers Squibb Announces Dividend

June 17, 2026

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-three cents ($0.63) per share on the $0.10 par value common stock of the company.

The dividend is payable on August 3, 2026, to stockholders of record at the close of business on July 2, 2026.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science

At Bristol Myers Squibb, our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information about Bristol Myers Squibb, visit us at BMS.com and follow us on LinkedIn , X , YouTube , Facebook , and Instagram .

corporatefinancial-news

Source: Bristol Myers Squibb

Media downloads:

Categories: Press Releases

Related news

BMYBristol-Myers Squibb Company

Bristol Myers Squibb develops and commercializes medicines across oncology, hematology, immunology, and cardiovascular disease. Its market story is driven by cash flow durability, pipeline replacement, and lifecycle pressure across a large commercial base.

Recent company news

Stock data

Close
64.15 USD
Market cap
111.21B USD
Exchange
NYSE
Sector
Oncology, Immunotherapy
Location
Princeton, New Jersey